Innate Pharma SA banner

Multiples-Based Value

The Multiples-Based Value for Innate Pharma SA (IDD) under the Base Case is 0.912 EUR. Compared with the current market price of 1.598 EUR, the stock appears Overvalued by 43% .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IDD Multiples-Based Value
Base Case
€0.912
Overvaluation 43%
Multiples-Based Value
Price €1.598

Multiples Across Competitors

IDD Competitors Multiples
Innate Pharma SA Competitors